Analyst firms · Mizuho · AMLX

Mizuho AMLX price target and rating history

Amylyx Pharmaceuticals Inc. (AMLX) · Health Care

Mizuho rates Amylyx Pharmaceuticals Inc. (AMLX) Outperform with a $7 price target, as of its latest action on Apr 7, 2025. It has published 3 rating actions on AMLX since March 2023, including 1 upgrade and 1 downgrade.

Current rating
Outperform
Price target
$7
Median target, all firms
Too few
Actions on AMLX
3

Mizuho price target on AMLX

$52$28$4202420252026
Mizuho price target on AMLX, each point a stated target, March 2023 to April 2025.

Every Mizuho rating on AMLX

Questions about Mizuho and AMLX

What is Mizuho's price target for AMLX?
Mizuho's latest stated price target for Amylyx Pharmaceuticals Inc. (AMLX) is $7, from its action on Apr 7, 2025.
What is Mizuho's rating on AMLX?
Mizuho rates AMLX Outperform, a bullish rating, as of Apr 7, 2025.
When did Mizuho last change its view on AMLX?
On Apr 7, 2025, Mizuho upgrades to Outperform from Neutral, price target $7.

More AMLX rating histories

All Mizuho ratingsAMLX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.